How a Tiny Breast Cancer Device Carries Big Value

With all the uncertainty in today's healthcare system, the one thing everyone seems to agree on is that value-based care is here to stay. Cianna Medical understands that particularly well, and the company's latest FDA clearance is expected to add even more value to the continuum of care for breast cancer patients and their providers. Cianna's Savi Scout reflector can now be implanted in breast cancer patients without restrictions on the length of time that it can remain in the breast. The device is a non-radioactive implant used in wire-free localization. It is only activated when a special handpiece, which acts as the radar system, is placed on the breast at the time of the procedure to locate the reflector. Before this clearance, the reflector was allowed to stay implanted for up to 30 days. "We're replacing a 30-year-old technology called wire localization," CEO Jill Anderson told MD+DI Qmed. "In that technique, ladies would go into radiology the morning of their surgery and they would place a wire into the breast with the theory that the bottom of the wire would be at the tumor location and the proximal end of that wire would then be hanging from the breast. And then, when the ladies were in the OR, the surgeons could see the entry location, which may or may not relate linearly to where the tissue is that they need to remove and then they would use that wire to guide them down to the tissue that needed to be removed." The wire localization technique is less than efficient...
Source: MDDI - Category: Medical Devices Authors: Tags: Implants Source Type: news